Skip to content

RayzeBio, Inc.

CIK 0001825367

← back to feed
Revenue (TTM)
—
Q3 Nov 2023
Net Income (TTM)
—
Q3 Nov 2023
EPS Diluted (TTM)
—
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
—
Q3 Nov 2023
Net Margin
—
Q3 Nov 2023
Free Cash Flow (TTM)
—
Q3 Nov 2023
Cash
$251.96M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
59.92M sh
Q3 Nov 2023

Recent filings